204 related articles for article (PubMed ID: 20049867)
21. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
22. Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks.
Zhang Y; Wolf-Yadlin A; White FM
Methods Mol Biol; 2007; 359():203-12. PubMed ID: 17484120
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of enrichment techniques for mass spectrometry: identification of tyrosine phosphoproteins in cancer cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
J Mol Diagn; 2007 Apr; 9(2):169-77. PubMed ID: 17384208
[TBL] [Abstract][Full Text] [Related]
24. Analysis of dynamic tyrosine phosphoproteome in LFA-1 triggered migrating T-cells.
Verma NK; Dempsey E; Freeley M; Botting CH; Long A; Kelleher D; Volkov Y
J Cell Physiol; 2011 Jun; 226(6):1489-98. PubMed ID: 20945386
[TBL] [Abstract][Full Text] [Related]
25. Targeted quantitative phosphoproteomics approach for the detection of phospho-tyrosine signaling in plants.
Mithoe SC; Boersema PJ; Berke L; Snel B; Heck AJ; Menke FL
J Proteome Res; 2012 Jan; 11(1):438-48. PubMed ID: 22074104
[TBL] [Abstract][Full Text] [Related]
26. Global analysis of protein phosphorylation networks in insulin signaling by sequential enrichment of phosphoproteins and phosphopeptides.
Fedjaev M; Parmar A; Xu Y; Vyetrogon K; Difalco MR; Ashmarina M; Nifant'ev I; Posner BI; Pshezhetsky AV
Mol Biosyst; 2012 Apr; 8(5):1461-71. PubMed ID: 22362066
[TBL] [Abstract][Full Text] [Related]
27. [Phosphoprotein affinity profiling--a novel method for screening regulators of lipopolysaccharide signaling pathway].
Zou ZP; Li YS; Chen J; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):766-70. PubMed ID: 17584634
[TBL] [Abstract][Full Text] [Related]
28. Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters.
Abe Y; Nagano M; Tada A; Adachi J; Tomonaga T
J Proteome Res; 2017 Feb; 16(2):1077-1086. PubMed ID: 28152594
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Haake SM; Li J; Bai Y; Kinose F; Fang B; Welsh EA; Zent R; Dhillon J; Pow-Sang JM; Chen YA; Koomen JM; Rathmell WK; Fishman M; Haura EB
Clin Cancer Res; 2016 Nov; 22(22):5605-5616. PubMed ID: 27220961
[TBL] [Abstract][Full Text] [Related]
30. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways.
Kosako H; Nagano K
Expert Rev Proteomics; 2011 Feb; 8(1):81-94. PubMed ID: 21329429
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.
van der Mijn JC; Labots M; Piersma SR; Pham TV; Knol JC; Broxterman HJ; Verheul HM; Jiménez CR
J Proteomics; 2015 Sep; 127(Pt B):259-63. PubMed ID: 25890253
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the promiscuous nature of tyrosine kinase inhibitors assessed in A431 epidermoid carcinoma cells by both chemical- and phosphoproteomics.
Giansanti P; Preisinger C; Huber KV; Gridling M; Superti-Furga G; Bennett KL; Heck AJ
ACS Chem Biol; 2014 Jul; 9(7):1490-8. PubMed ID: 24804581
[TBL] [Abstract][Full Text] [Related]
33. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase,
Goel RK; Paczkowska M; Reimand J; Napper S; Lukong KE
Mol Cell Proteomics; 2018 May; 17(5):925-947. PubMed ID: 29496907
[TBL] [Abstract][Full Text] [Related]
34. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
Li J; Rix U; Fang B; Bai Y; Edwards A; Colinge J; Bennett KL; Gao J; Song L; Eschrich S; Superti-Furga G; Koomen J; Haura EB
Nat Chem Biol; 2010 Apr; 6(4):291-9. PubMed ID: 20190765
[TBL] [Abstract][Full Text] [Related]
35. Strategies for quantitation of phosphoproteomic data.
Palmisano G; Thingholm TE
Expert Rev Proteomics; 2010 Jun; 7(3):439-56. PubMed ID: 20536313
[TBL] [Abstract][Full Text] [Related]
36. Phosphoproteomic analysis of Her2/neu signaling and inhibition.
Bose R; Molina H; Patterson AS; Bitok JK; Periaswamy B; Bader JS; Pandey A; Cole PA
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9773-8. PubMed ID: 16785428
[TBL] [Abstract][Full Text] [Related]
37. Analysis of phosphoproteomics data.
Schaab C
Methods Mol Biol; 2011; 696():41-57. PubMed ID: 21063940
[TBL] [Abstract][Full Text] [Related]
38. Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study.
Yan GR; Zou FY; Dang BL; Zhang Y; Yu G; Liu X; He QY
Proteomics; 2012 Aug; 12(14):2391-9. PubMed ID: 22887948
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three quantitative phosphoproteomic strategies to study receptor tyrosine kinase signaling.
Zhang G; Neubert TA
J Proteome Res; 2011 Dec; 10(12):5454-62. PubMed ID: 22013880
[TBL] [Abstract][Full Text] [Related]
40. Laminin stimulates protein tyrosine dephosphorylation in PC12 cells.
Weeks BS; Wilson PJ; Heffernan CC; Gorra VA; White LE; Ahmad A
Biochem Biophys Res Commun; 1999 Sep; 262(3):713-9. PubMed ID: 10471391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
